These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2016248)

  • 61. Buspirone, anxiety, and sleep.
    Hvizdos AJ; Seidehamel RJ
    Am J Psychiatry; 1993 May; 150(5):845-6. PubMed ID: 8480848
    [No Abstract]   [Full Text] [Related]  

  • 62. [Efficacy of and tolerance to buspirone hydrochloride in the treatment of psychosomatic symptoms in clinical cardiology].
    Ramires JA; Solimene MC; Serrano Júnior CV; Mansur Ade P; Pileggi F
    Arq Bras Cardiol; 1993 Apr; 60(4):269-72. PubMed ID: 8311738
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Buspirone treatment of psychiatrically hospitalized prepubertal children with symptoms of anxiety and moderately severe aggression.
    Pfeffer CR; Jiang H; Domeshek LJ
    J Child Adolesc Psychopharmacol; 1997; 7(3):145-55. PubMed ID: 9466232
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Buspirone in drug users with AIDS or AIDS-related complex.
    Batki SL
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):111S-115S. PubMed ID: 2376626
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of generalized anxiety disorder and trichotillomania with buspirone.
    Reid TL
    Am J Psychiatry; 1992 Apr; 149(4):573-4. PubMed ID: 1554051
    [No Abstract]   [Full Text] [Related]  

  • 66. Buspirone, a new approach to the treatment of anxiety.
    Taylor DP
    FASEB J; 1988 Jun; 2(9):2445-52. PubMed ID: 2836252
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Buspirone for the Treatment of Generalized Anxiety Disorder in Down Syndrome: 3 Cases.
    Howe YJ; Thom RP; Notson EE; McDougle CJ; Palumbo ML
    J Dev Behav Pediatr; 2022 Jan; 43(1):38-43. PubMed ID: 33965971
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Buspirone-associated mental status changes.
    Soni P; Weintraub AL
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1098-9. PubMed ID: 1429411
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Stability of territorial and aggressive behavior in profoundly mentally retarded institutionalized male adults.
    Rago WV
    Am J Ment Defic; 1978 Mar; 82(5):494-8. PubMed ID: 637071
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Low-dose buspirone to treat agitation and maladaptive behavior in brain-injured patients: two case reports.
    Ratey JJ; Leveroni CL; Miller AC; Komry V; Gaffar K
    J Clin Psychopharmacol; 1992 Oct; 12(5):362-4. PubMed ID: 1479058
    [No Abstract]   [Full Text] [Related]  

  • 71. Buspirone--frontrunner of a new genre of anxiolytics.
    Straughan JL; Conradie EA
    S Afr Med J; 1988 Nov; 74(9):441-4. PubMed ID: 3055361
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Use of buspirone in an adolescent with overanxious disorder.
    Kranzler HR
    J Am Acad Child Adolesc Psychiatry; 1988 Nov; 27(6):789-90. PubMed ID: 3198569
    [No Abstract]   [Full Text] [Related]  

  • 73. Euphoria with buspirone after fluoxetine treatment.
    Lebert F; Pasquier F; Goudemand M; Petit H
    Am J Psychiatry; 1993 Jan; 150(1):167. PubMed ID: 8417565
    [No Abstract]   [Full Text] [Related]  

  • 74. Long-term buspirone therapy for chronic anxiety: a multicenter international study to determine safety.
    Rakel RE
    South Med J; 1990 Feb; 83(2):194-8. PubMed ID: 2406933
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Explorative single-blind study on the sedative and hypnotic effects of buspirone in anxiety patients.
    De Roeck J; Cluydts R; Schotte C; Rouckhout D; Cosyns P
    Acta Psychiatr Scand; 1989 Feb; 79(2):129-35. PubMed ID: 2923006
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Alprazolam plus buspirone in treatment of anxiety.
    Tollefson GD; Montague-Clouse J
    Am J Psychiatry; 1988 Mar; 145(3):379-80. PubMed ID: 3344857
    [No Abstract]   [Full Text] [Related]  

  • 77. [Buspirone: pharmacological and clinical properties of the first member of a new anxiolytic drug family].
    Bonvalot T; Boulenger JP; Zarifian E
    Rev Med Interne; 1988; 9(1):97-103. PubMed ID: 3285427
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Buspirone for aggression.
    Quiason N; Ward D; Kitchen T
    J Am Acad Child Adolesc Psychiatry; 1991 Nov; 30(6):1026. PubMed ID: 1757432
    [No Abstract]   [Full Text] [Related]  

  • 79. Treatment of aggression in juvenile-onset Huntington's disease with buspirone.
    Findling RL
    Psychosomatics; 1993; 34(5):460-1. PubMed ID: 8140199
    [No Abstract]   [Full Text] [Related]  

  • 80. Buspirone treatment of anxious alcoholics. A placebo-controlled trial.
    Kranzler HR; Burleson JA; Del Boca FK; Babor TF; Korner P; Brown J; Bohn MJ
    Arch Gen Psychiatry; 1994 Sep; 51(9):720-31. PubMed ID: 8080349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.